Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Colon Cancer Stage III Clinical Trial

Official title:
A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).

Status Completed

Clinical Trial Summary

This clinical investigation examined the effectivity 5-fluorouracil, of adding levamisol or interferon to 5-fluorouracil, and of a 5-fluorouracil/levamisol/interferon triple combination, in terms of recurrence-free and overall survival in curatively operable colon carcinoma Stage III.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Colon Cancer Stage III

Clinical Trial Details

NCT number	NCT00309530
Study type	Interventional
Source	Austrian Breast & Colorectal Cancer Study Group
Contact
Status	Completed
Phase	Phase 3
Start date	October 1990

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Completed	`NCT04342676` - Lymph Node Ratio and Kras Mutation in R Colon Cancer	Phase 3
Enrolling by invitation	`NCT05179889` - Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer	Phase 2/Phase 3
Withdrawn	`NCT05433402` - Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer	Phase 1/Phase 2
Recruiting	`NCT06108310` - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Withdrawn	`NCT05310565` - The Effects of Chiropractic in Adults With Colon Cancer	N/A
Not yet recruiting	`NCT04488159` - Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer	Phase 3
Recruiting	`NCT05194878` - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers	Phase 3